Rentokil Initial Plc Stock Shares Outstanding
| RTO Stock | USD 25.62 0.65 2.47% |
Rentokil Initial PLC fundamentals help investors to digest information that contributes to Rentokil Initial's financial success or failures. It also enables traders to predict the movement of Rentokil Stock. The fundamental analysis module provides a way to measure Rentokil Initial's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rentokil Initial stock.
As of the 1st of May 2024, Common Stock Shares Outstanding is likely to grow to about 2.7 B. Rentokil | Shares Outstanding |
Rentokil Initial PLC Company Shares Outstanding Analysis
Rentokil Initial's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Rentokil Initial Shares Outstanding | 502.31 M |
Most of Rentokil Initial's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rentokil Initial PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Rentokil Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Rentokil Initial is extremely important. It helps to project a fair market value of Rentokil Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Rentokil Initial's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rentokil Initial's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rentokil Initial's interrelated accounts and indicators.
Click cells to compare fundamentals
Rentokil Shares Outstanding Historical Pattern
Today, most investors in Rentokil Initial Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rentokil Initial's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Rentokil Initial shares outstanding as a starting point in their analysis.
Rentokil Initial Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Rentokil Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Rentokil Initial PLC has 502.31 M of shares currently outstending. This is 244.65% higher than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The shares outstanding for all United States stocks is 12.16% higher than that of the company.
Rentokil Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rentokil Initial's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rentokil Initial could also be used in its relative valuation, which is a method of valuing Rentokil Initial by comparing valuation metrics of similar companies.Rentokil Initial is currently under evaluation in shares outstanding category among related companies.
Rentokil Initial Current Valuation Drivers
We derive many important indicators used in calculating different scores of Rentokil Initial from analyzing Rentokil Initial's financial statements. These drivers represent accounts that assess Rentokil Initial's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Rentokil Initial's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 42.5B | 48.3B | 55.2B | 51.2B | 46.0B | 48.3B | |
| Enterprise Value | 43.5B | 49.5B | 56.5B | 54.4B | 48.9B | 51.4B |
Rentokil Fundamentals
| Return On Equity | 0.0931 | ||||
| Return On Asset | 0.0394 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 69.13 B | ||||
| Shares Outstanding | 502.31 M | ||||
| Shares Owned By Institutions | 12.20 % | ||||
| Number Of Shares Shorted | 5.43 M | ||||
| Price To Earning | 38.73 X | ||||
| Price To Book | 2.78 X | ||||
| Price To Sales | 2.66 X | ||||
| Revenue | 5.38 B | ||||
| Gross Profit | 536 M | ||||
| EBITDA | 1.36 B | ||||
| Net Income | 381 M | ||||
| Cash And Equivalents | 2.17 B | ||||
| Cash Per Share | 6.38 X | ||||
| Total Debt | 4.73 B | ||||
| Debt To Equity | 2.64 % | ||||
| Current Ratio | 1.88 X | ||||
| Book Value Per Share | 1.63 X | ||||
| Cash Flow From Operations | 741 M | ||||
| Short Ratio | 8.39 X | ||||
| Earnings Per Share | 0.94 X | ||||
| Price To Earnings To Growth | 0.78 X | ||||
| Target Price | 32.06 | ||||
| Number Of Employees | 62.93 K | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 13.2 B | ||||
| Total Asset | 11.13 B | ||||
| Retained Earnings | 6.52 B | ||||
| Working Capital | 118 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 11.13 B | ||||
| Last Dividend Paid | 0.087 |
About Rentokil Initial Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rentokil Initial PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rentokil Initial using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rentokil Initial PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rentokil Initial in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rentokil Initial's short interest history, or implied volatility extrapolated from Rentokil Initial options trading.
Currently Active Assets on Macroaxis
When determining whether Rentokil Initial PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rentokil Initial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rentokil Initial Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rentokil Initial Plc Stock:Check out Rentokil Initial Piotroski F Score and Rentokil Initial Altman Z Score analysis. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Rentokil Stock analysis
When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Rentokil Initial's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rentokil Initial. If investors know Rentokil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rentokil Initial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.557 | Dividend Share 0.087 | Earnings Share 0.94 | Revenue Per Share 10.68 | Quarterly Revenue Growth 0.262 |
The market value of Rentokil Initial PLC is measured differently than its book value, which is the value of Rentokil that is recorded on the company's balance sheet. Investors also form their own opinion of Rentokil Initial's value that differs from its market value or its book value, called intrinsic value, which is Rentokil Initial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rentokil Initial's market value can be influenced by many factors that don't directly affect Rentokil Initial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rentokil Initial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rentokil Initial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rentokil Initial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.